- Filed
- Apr 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Apr 15, 2021 | 5.1B sh |
| Shares Diluted | FY 2020 · Dec 31, 2019 | 1.25B sh |
| Capex | FY 2020 · Dec 31, 2019 | $2.74M |
| Operating Cash Flow restated | FY 2020 · Dec 31, 2019 | $106.95K |
| Long Term Debt | FY 2020 · Dec 31, 2019 | $3.12M |
| Short Term Debt | FY 2020 · Dec 31, 2019 | $2.71M |
| Stockholders Equity restated | FY 2020 · Dec 31, 2019 | −$3.14M |
| Current Liabilities restated | FY 2020 · Dec 31, 2019 | $9.12M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $12.24M |
| Current Assets | FY 2020 · Dec 31, 2019 | $2.07M |
| Total Assets | FY 2020 · Dec 31, 2019 | $9.24M |
| Sga Expense restated | FY 2020 · Dec 31, 2019 | $1.16M |
| Net Income | FY 2020 · Dec 31, 2019 | −$5.46M |
| Operating Income restated | FY 2020 · Dec 31, 2019 | −$2.12M |
| Cost Of Revenue restated | FY 2020 · Dec 31, 2019 | $1.08M |
| Revenue restated | FY 2020 · Dec 31, 2019 | $4.1M |
| Cash And Equivalents | FY 2020 · Dec 31, 2018 | $79.89K |